June 2014 Issue Table Of Contents

From The Editor

• Drug Development – You Get What You Incentivize For

Feature Articles

• Eli Lilly Navigates The Realities Of Innovation
• Genzum Plies The Art & Science Of Scaling Up
• Lessons Learned Help Pfizer Accelerate Biotherapeutic Development
• Life Science Partnerships With Patient Foundations: The Best Practices

Capitol Perspectives

• Dysfunctional Tax Policy harming Life Science Innovation And Jobs

Companies To Watch

• A Product For Gaucher Disease And A Plant-Cell For Protein Production – Protalix Biotherapeutics Is On The Rise

Outsourcing Insights

• As Outsourcing Relationships Evolve, Vaccine Production Will Continue To Shift To CMOs

Bio Innovation notes

• Bioprocessors Demanding Single-Use Sensors

Inside The Industry

• Navigating The New World Of Value-Based Healthcare
• How Genzyme Got Its Manufacturing Mojo Back
• 3D Bioprinting Could Speed Up Drug Development

Industry Leader

• Bridging the Gap In the Clinical Development Business Model With Patient Involvement
• Molecular Imaging Cuts Time And Cost From Drug Discovery

Leadership Lessons

• Leadership Lessons: The Essential Leadership Practice to Inspiring Employee Engagement

Ask The Board

• Ask The Board